1. Auerswald, G., Noväkova-Banet, A., Heimburger, N., Popp, M.: New pasteurized factor IX concentrate: Manufacturing, clinical efficacy and hepatitis safety. Sonderdruck von Beiträgen des XVI. International Congress WFH. Rio de Janeiro 24. - 28. August 1984 Behring-Werke Marburg/Lahn, pp. 15–19
2. Alter, H.J.: Posttransfusion hepatitis: Clinical features, risk and donor testing. In: Dodd, R.Y., Barker, L.F. (Ed.) Infection, immunity and blood transfusion. Allan R. Liss, New York, pp. 47–61 (1985)
3. Colombo, M., Carneli, V., Gazengel, C., Mannucci, P.M, Savidge, G.F., Schimpf, Kl.: Transmission of Non-A, non-B-Hepatitis by heat-treated factor VIII concentrate. Lancet II, 1–4 (1985)
4. Fletcher, M.L., Trowel 1, J.M., Craske, J., Pavier, K., Rizza, C.R.: Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Brit. med. J., 1754–1757 (1983)
5. Heinrich, D., Kotitschke, R., Berthold, H.: Clinical evaluation of the hepatitis safety of a beta-Propiolactone/ultra violet treated factor IX concentrate (PPSB). Thrombosis ressarge 28, 75–83 (1982)